| Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection (NCT01915212) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-09-26 |
| Fat Metabolism and Melanocortin 3 Receptors in African Americans (NCT01851421) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2013-09-23 |
| Simultaneous MEG or fMRI And INtracranial EEG (NCT02342938) | Hospices Civils de Lyon | 2013-09-16 |
| Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg. (NCT01935570) | University Hospital, Clermont-Ferrand | 2013-09-01 |
| Relaxing Effects of Acupuncture, Sham Acupuncture or no Acupuncture (NCT03441698) | Västernorrland County Council, Sweden | 2013-09-01 |
| A Study of Baricitinib and Probenecid in Healthy Participants (NCT01937026) | Eli Lilly and Company | 2013-09-01 |
| AZD6423 SAD/MAD Study in Healthy Volunteers (NCT01926366) | AstraZeneca | 2013-09-01 |
| MLN3126 Single Rising Dose Study (NCT02447458) | Takeda | 2013-09-01 |
| Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects (NCT01894399) | Hanmi Pharmaceutical Company Limited | 2013-09-01 |
| Tear Collection in Adult Volunteers (NCT01969162) | Allergan | 2013-09-01 |
| Multi-scale Modeling of Sleep Behaviors in Social Networks (NCT02846077) | Brigham and Women's Hospital | 2013-09-01 |
| A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers (NCT01855048) | Intron Biotechnology, Inc. | 2013-08-06 |
| Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration (NCT01929213) | Dong-A Pharmaceutical Co., Ltd. | 2013-08-01 |
| LAAM-HAART PET Imaging (NCT01935830) | Washington University School of Medicine | 2013-08-01 |
| A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants (NCT01924299) | Eli Lilly and Company | 2013-08-01 |
| A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers (NCT01954238) | Green Cross Corporation | 2013-08-01 |
| An Ascending Single-Dose Study of the Safety, Tolerability and Bioeffect of REGN1193 (NCT01933763) | Regeneron Pharmaceuticals | 2013-08-01 |
| Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003 (NCT01992367) | ASLAN Pharmaceuticals | 2013-08-01 |
| A Study of Baricitinib and Rifampicin in Healthy Participants (NCT01910311) | Eli Lilly and Company | 2013-08-01 |
| Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786) (NCT01910220) | Regeneron Pharmaceuticals | 2013-08-01 |
| A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants (NCT01913314) | Eli Lilly and Company | 2013-08-01 |
| A Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy Subjects (NCT01893866) | Pfizer | 2013-08-01 |
| Compare the Same Dosage of Insulin Using a Combination of Cartridges, 30 Units as 2 Cartridges vs. 1 Cartridge (NCT01902121) | Mannkind Corporation | 2013-08-01 |
| Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers (NCT01890785) | Shire | 2013-07-15 |
| Black Raspberry Confection in Preventing Oral Cancer in Healthy Volunteers (NCT01961869) | Ohio State University Comprehensive Cancer Center | 2013-07-02 |
| Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass (NCT02236754) | Columbia University | 2013-07-02 |
| A Study of Baricitinib and Birth Control Pills in Healthy Females (NCT01896726) | Eli Lilly and Company | 2013-07-01 |
| A Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Participants (NCT01897389) | Janssen Research & Development, LLC | 2013-07-01 |
| Bioequivalence Study to Evaluate the Impact of Varying Crystalline Polymorph Forms for the Commercial Oral Capsule Formulation of 10-mg Lenvatinib in Healthy Volunteers (NCT02723630) | Eisai Inc. | 2013-07-01 |
| A Study of Evacetrapib (LY2484595) in Healthy Participants (NCT01903434) | Eli Lilly and Company | 2013-07-01 |
| A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV16) Inoculum in Healthy Volunteers (NCT01769573) | University of Wisconsin, Madison | 2013-07-01 |
| CC-223 and Ketoconazole Drug-Drug Interaction Study (NCT01896323) | Celgene | 2013-07-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects (NCT01897779) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2013-07-01 |
| SENSIMED Triggerfish Sensor Sizes (NCT01972997) | Sensimed AG | 2013-07-01 |
| Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations (NCT02023489) | Medical University of Vienna | 2013-07-01 |
| A Study of Evacetrapib and Rifampin in Healthy Participants (NCT01908582) | Eli Lilly and Company | 2013-07-01 |
| A Study of Evacetrapib and Digoxin in Healthy Participants (NCT01897493) | Eli Lilly and Company | 2013-07-01 |
| Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules (NCT05436886) | University of Karachi | 2013-06-28 |
| A Study of LY2605541 in Healthy Participants (NCT01877265) | Eli Lilly and Company | 2013-06-01 |
| ADASUVE-Lorazepam Drug-Drug Interaction (NCT01877642) | Alexza Pharmaceuticals, Inc. | 2013-06-01 |
| Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers (NCT01893528) | Regeneron Pharmaceuticals | 2013-06-01 |
| Strength and Balance in Gender- and Age-Matched Controls (NCT02110875) | Oregon Health and Science University | 2013-06-01 |
| Brain During Effort : Effects of Hypoxia With Respiratory Patients (NCT02854280) | University Hospital, Grenoble | 2013-06-01 |
| A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants (NCT01871493) | Eli Lilly and Company | 2013-06-01 |
| Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Healthy Volunteers (NCT02790411) | University Hospital, Grenoble | 2013-05-21 |
| A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants (NCT01821703) | Eli Lilly and Company | 2013-05-01 |
| A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants (NCT01859078) | Eli Lilly and Company | 2013-05-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 (NCT01813084) | Respivert Ltd | 2013-05-01 |
| A Study of LY3084077 in Healthy Participants (NCT01846702) | Eli Lilly and Company | 2013-05-01 |
| A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants (NCT01873001) | Janssen Research & Development, LLC | 2013-05-01 |
| Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations (NCT01859377) | Pierre Fabre Medicament | 2013-05-01 |
| ADASUVE 2-dose Thorough QT/QTc Study (NCT01854710) | Alexza Pharmaceuticals, Inc. | 2013-05-01 |
| Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects (NCT01861626) | Pierre Fabre Dermatology | 2013-05-01 |
| The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream (NCT01836198) | Eli Lilly and Company | 2013-05-01 |
| A Multiple Dose Study of LY3023703 in Healthy Participants (NCT01849055) | Eli Lilly and Company | 2013-05-01 |
| Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance (NCT01906203) | University Hospital, Clermont-Ferrand | 2013-05-01 |
| Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects (NCT01918995) | Astellas Pharma Global Development, Inc. | 2013-05-01 |
| 3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 and Relative Bioavailability of a Formulated CC-220 Capsule (NCT02034773) | Celgene Corporation | 2013-05-01 |
| Magnetic Resonance Imaging (MRI) Sequences Optimization in Healthy Subjects (NCT02900339) | Rennes University Hospital | 2013-04-18 |
| Safety and Tolerability Study With Single Ascending Doses of ODM-102 (NCT01839019) | Orion Corporation, Orion Pharma | 2013-04-01 |
| Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet Action (NCT02060396) | Aragon Institute of Health Sciences | 2013-04-01 |
| A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants (NCT01825876) | Eli Lilly and Company | 2013-04-01 |
| Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase I Study in Chinese Healthy Volunteers (NCT01901198) | Beijing Bio-Fortune Ltd. | 2013-04-01 |
| A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers (NCT01796327) | Pfizer | 2013-04-01 |
| Adsorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled SPD557 in Volunteers (NCT01786876) | Shire | 2013-03-07 |
| A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease (NCT01807026) | Eli Lilly and Company | 2013-03-01 |
| Multi-cycle Prolon Diet (NCT02158897) | University of Southern California | 2013-03-01 |
| Study of Food on Evacetrapib (LY2484595) in Healthy Participants (NCT01810432) | Eli Lilly and Company | 2013-03-01 |
| A Study of LY2605541 in Healthy Participants and in the Elderly (NCT01818245) | Eli Lilly and Company | 2013-03-01 |
| The Operation of Control Devices During Parabolic Flights: Influence of Weightlessness, Stress and Motivation (NCT02563275) | University Hospital, Caen | 2013-03-01 |
| Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination (NCT01772836) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2013-03-01 |
| A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765 (NCT01820936) | Janssen Research & Development, LLC | 2013-03-01 |
| Reliability of a Masseter Muscle Prominence Scale and Lower Facial Shape Classification (NCT01821534) | Allergan | 2013-03-01 |
| Comparison of Ultrafast Echo With Echotracking (NCT01743352) | French Cardiology Society | 2013-03-01 |
| Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector (NCT01765426) | Takeda | 2013-02-15 |
| Global Positioning Satellite and Accelerometry to Assess Human Locomotion (ACTI GPS) (NCT01805219) | University Hospital, Angers | 2013-02-01 |
| Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days (NCT01786915) | Stealth BioTherapeutics Inc. | 2013-02-01 |
| A Study of Two Dosage Forms of LY2886721 in Healthy Participants (NCT01775904) | Eli Lilly and Company | 2013-02-01 |
| Bisnorcymserine in Healthy Adult Volunteers (NCT01747213) | National Institute on Aging (NIA) | 2013-01-29 |
| A Study of LY3045697 in Healthy Participants (NCT01750853) | Eli Lilly and Company | 2013-01-01 |
| A Study of LY2157299 Monohydrate in Healthy Volunteers (NCT01746004) | Eli Lilly and Company | 2013-01-01 |
| A Healthy Subject Study With Z-360 and Placebo (NCT01776463) | Zeria Pharmaceutical | 2013-01-01 |
| A Study of LY2940680 in Healthy Participants (NCT01746745) | Eli Lilly and Company | 2013-01-01 |
| The Effects of Physical Training on Physiological and Psychological Stress-reactions and Cognitive Function. (NCT02051127) | Vastra Gotaland Region | 2013-01-01 |
| Glyburide Healthy Volunteer Study (NCT01716338) | Washington University School of Medicine | 2013-01-01 |
| A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults (NCT01779505) | Gilead Sciences | 2013-01-01 |
| The Relationship Between Cardiac Output and Microvascular Visceral Blood Flow (NCT02167178) | University of Nottingham | 2013-01-01 |
| Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers (NCT01796899) | UCB Pharma SA | 2013-01-01 |
| Evaluation of Glycemic Index, Glycemic Load and Insulinemic Index of Spanish Breads (NCT02297074) | Organización Interprofesional Agroalimentaria de Cereales Panificables y Derivados | 2013-01-01 |
| Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels (NCT01749085) | Pfizer | 2012-12-01 |
| Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 1 of 4) (NCT01758432) | Portola Pharmaceuticals | 2012-12-01 |
| A Study of LY3053102 in Healthy Participants (NCT01736241) | Eli Lilly and Company | 2012-12-01 |
| Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4) (NCT03578146) | Portola Pharmaceuticals | 2012-12-01 |
| Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4) (NCT03551730) | Portola Pharmaceuticals | 2012-12-01 |
| Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 4 of 4) (NCT03551743) | Portola Pharmaceuticals | 2012-12-01 |
| A Study of Evacetrapib in Healthy Participants (NCT01736254) | Eli Lilly and Company | 2012-12-01 |
| Mercury Versus Automated Blood Pressure Monitoring (NCT01753895) | Rockefeller University | 2012-12-01 |
| A Single Dose Study of LY2605541 in Participants With Liver Impairment (NCT01751399) | Eli Lilly and Company | 2012-12-01 |
| Metabolic Flexibility as a Biomarker of Adaptation to Diet and Exercise Challenges (NCT01987388) | USDA Beltsville Human Nutrition Research Center | 2012-12-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects (NCT01751269) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2012-12-01 |